Peer Review Policy

The Journal follows a double-blind peer review process in which neither the authors nor the peer reviewers know each other's details. The submitted manuscripts will be reviewed for originality, scientific significance, and adequacy of documentation by independent subject experts who are not members of the editorial board. Further, reviewers are also required to disclose any competing interests (e.g., affiliation with the drug company tested in the study) regarding the manuscripts they are going to review. In case of any conflict of interest, another subject expert will be invited to review the manuscript. Before forwarding the manuscript to peer reviewers, any identifiable information about the authors, including their names, affiliations, and contact details will be removed from the manuscript. All the manuscripts submitted will be initially scrutinized within a week for completeness and formatting by the editorial staff. The manuscripts not prepared according to the instructions will be returned to the authors for any corrections/modifications before sending them for peer review. While the manuscripts prepared according to the prescribed guidelines will be sent for peer review to at least two independent subject experts (i.e., subject experts affiliated to a different institute than the authors' institute). According to the reviewers ' recommendations, the manuscripts will be accepted, rejected, or returned to the authors for modifications. In case of a difference of opinion among both subject experts, the manuscript will be sent to a third reviewer. All parts of accepted manuscripts are subject to editing for scientific accuracy and clarity by the office of the Editor. The manuscripts will undergo copyediting (including modifications in the text, table, figures) and layout formatting by the editorial staff. The corresponding author will receive an edited manuscript (galley proof) for final approval before publishing. All co-authors should review this carefully as they will be responsible for all changes in their work, including changes made by the copy editors. The names of the reviewers and their reviews will be strictly kept confidential and will not be disclosed at any point. Reviewers are expected to keep the scientific data strictly confidential and not keep its record or share it with any other colleague. Reviewers must also not use/quote data from the manuscript under review before publication. At least two subject specialists will review all submissions, and their evaluation will be communicated to the authors. The editorial board entertains articles on a first-come, first-served basis and does not guarantee to publish an accepted article in any particular issue.